Naomi Lowe

1.9k total citations
16 papers, 915 citations indexed

About

Naomi Lowe is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Naomi Lowe has authored 16 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Cognitive Neuroscience. Recurrent topics in Naomi Lowe's work include Attention Deficit Hyperactivity Disorder (13 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Bipolar Disorder and Treatment (6 papers). Naomi Lowe is often cited by papers focused on Attention Deficit Hyperactivity Disorder (13 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Bipolar Disorder and Treatment (6 papers). Naomi Lowe collaborates with scholars based in Ireland, United States and Germany. Naomi Lowe's co-authors include Ziarih Hawi, Michael Gill, Aiveen Kirley, Michael Fitzgerald, Celine Mullins, Nick Craddock, Lindsey Kent, Mary McCarron, Irwin D. Waldman and Katherine M. Sheehan and has published in prestigious journals such as The American Journal of Human Genetics, Molecular Psychiatry and American Journal of Medical Genetics Part B Neuropsychiatric Genetics.

In The Last Decade

Naomi Lowe

15 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naomi Lowe Ireland 11 684 418 279 137 114 16 915
Monika Heine Germany 15 676 1.0× 591 1.4× 150 0.5× 139 1.0× 178 1.6× 18 1.1k
Jacques Eisenberg Israel 10 509 0.7× 302 0.7× 214 0.8× 86 0.6× 111 1.0× 15 695
Chika Sumiyoshi Japan 16 503 0.7× 336 0.8× 235 0.8× 109 0.8× 101 0.9× 39 890
S.B. Wigal United States 6 792 1.2× 448 1.1× 341 1.2× 108 0.8× 174 1.5× 12 1.1k
Jennifer Mohr United States 7 550 0.8× 420 1.0× 263 0.9× 87 0.6× 246 2.2× 8 871
Nina Roth Mota Netherlands 18 490 0.7× 321 0.8× 106 0.4× 166 1.2× 124 1.1× 57 902
Celine Mullins Ireland 8 415 0.6× 289 0.7× 152 0.5× 60 0.4× 72 0.6× 8 557
T E Goldberg United States 8 467 0.7× 464 1.1× 227 0.8× 53 0.4× 89 0.8× 17 853
Monika Deschner Germany 6 342 0.5× 258 0.6× 174 0.6× 62 0.5× 166 1.5× 7 591
Anna Bielsa Spain 12 633 0.9× 512 1.2× 128 0.5× 68 0.5× 54 0.5× 12 811

Countries citing papers authored by Naomi Lowe

Since Specialization
Citations

This map shows the geographic impact of Naomi Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Lowe more than expected).

Fields of papers citing papers by Naomi Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Lowe. The network helps show where Naomi Lowe may publish in the future.

Co-authorship network of co-authors of Naomi Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi Lowe. A scholar is included among the top collaborators of Naomi Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi Lowe. Naomi Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lowe, Naomi, et al.. (2025). Fears and uncertainties of people with Parkinson's disease. Journal of Parkinson s Disease. 15(3). 595–602.
2.
Fesharaki‐Zadeh, Arman, Naomi Lowe, & Amy F.T. Arnsten. (2022). Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”. PubMed Central. 3. 100154–100154. 18 indexed citations
3.
Hawi, Ziarih & Naomi Lowe. (2007). Molecular genetic aspects of attention deficit hyperactivity disorder. Queensland's institutional digital repository (The University of Queensland). 129–149. 3 indexed citations
4.
Lowe, Naomi, Edwina Barry, Michael Gill, & Ziarih Hawi. (2006). An Overview of the Pharmacogenetics and Molecular Genetics of ADHD. 4(3). 231–243. 5 indexed citations
5.
Domschke, Katharina, Karen Sheehan, Naomi Lowe, et al.. (2005). Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: Preferential transmission of the MAO‐A 941G allele to affected children. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 134B(1). 110–114. 63 indexed citations
6.
Bellgrove, Mark A., Ziarih Hawi, Naomi Lowe, et al.. (2005). DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): Effects of associated alleles at the VNTR and −521 SNP. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 136B(1). 81–86. 87 indexed citations
7.
Kent, Lindsey, Ziarih Hawi, Aiveen Kirley, et al.. (2005). Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Molecular Psychiatry. 10(10). 939–943. 107 indexed citations
8.
Sheehan, Katherine M., Naomi Lowe, Aiveen Kirley, et al.. (2005). Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Molecular Psychiatry. 10(10). 944–949. 110 indexed citations
9.
Hawi, Ziarih, Ricardo Segurado, Judith Conroy, et al.. (2005). Preferential Transmission of Paternal Alleles at Risk Genes in Attention-Deficit/Hyperactivity Disorder. The American Journal of Human Genetics. 77(6). 958–965. 61 indexed citations
10.
Kirley, Aiveen, Naomi Lowe, Celine Mullins, et al.. (2004). Phenotype studies of the DRD4 gene polymorphisms in ADHD: Association with oppositional defiant disorder and positive family history. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 131B(1). 38–42. 58 indexed citations
11.
Lowe, Naomi, Aiveen Kirley, Celine Mullins, et al.. (2004). Multiple marker analysis at the promoter region of the DRD4 gene and ADHD: Evidence of linkage and association with the SNP −616. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 131B(1). 33–37. 42 indexed citations
12.
Kirley, Aiveen, Naomi Lowe, Ziarih Hawi, et al.. (2003). Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 121B(1). 50–54. 121 indexed citations
13.
Hawi, Ziarih, Naomi Lowe, Aiveen Kirley, et al.. (2003). Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Molecular Psychiatry. 8(3). 299–308. 95 indexed citations
14.
Hawi, Ziarih, Katherine M. Sheehan, Aoibhinn Lynch, et al.. (2003). Late onset Alzheimer’s disease and apolipoprotein association in the Irish population: Relative risk and attributable fraction. Irish Journal of Medical Science (1971 -). 172(2). 74–76. 10 indexed citations
15.
Hawi, Ziarih, Aiveen Kirley, Naomi Lowe, Michael Fitzgerald, & Michael Gill. (2003). Recent genetic advances in ADHD and diagnostic and therapeutic prospects. Expert Review of Neurotherapeutics. 3(4). 453–464. 7 indexed citations
16.
Kent, Lindsey, Ziarih Hawi, Aiveen Kirley, et al.. (2002). Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Molecular Psychiatry. 7(8). 908–912. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Heine Breakdown of academic impact, for papers by Jacques Eisenberg Breakdown of academic impact, for papers by Chika Sumiyoshi Breakdown of academic impact, for papers by S.B. Wigal Breakdown of academic impact, for papers by Jennifer Mohr Breakdown of academic impact, for papers by Nina Roth Mota Breakdown of academic impact, for papers by Celine Mullins Breakdown of academic impact, for papers by T E Goldberg Breakdown of academic impact, for papers by Monika Deschner Breakdown of academic impact, for papers by Anna Bielsa
Rankless by CCL
2026